06-08-2020
The US Court of Appeals for the Federal Circuit will not revisit its ruling that saved the patent eligibility of two DNA test patents owned by biotechnology company Illumina, after the court rejected an en banc request from a subsidiary of Roche.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Illumina, Federal Circuit, DNA, pregnancy, biotechnology, Roche, Ariosa, foetal, patents, court, ruling, en banc
Roche urges SCOTUS to cancel Illumina patent win
08-01-2021
Fed Circuit throws out doctors’ patent suit
17-08-2020
McDermott hires Boston pair from Polsinelli
12-08-2020
Roche accuses competitor of infringing diabetes patent
22-06-2020
Fed Circuit restores two Illumina DNA patents in blow to Roche
19-03-2020
